• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bayer AG

Bayer AG

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

    Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

  2. Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

    Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol

  3. Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Diabetic Macular Edema (DME) in Japan

    Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Diabetic Macular Edema (DME) in Japan

  4. Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma

    Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma

  5. Research and Markets: Bone Metastasis Therapeutics Pipeline Review, H2 2014 - 19 Companies & 31 Drug Profiles

    Research and Markets: Bone Metastasis Therapeutics Pipeline Review, H2 2014 - 19 Companies & 31 Drug Profiles

  6. Regeneron Reports Third Quarter 2014 Financial and Operating Results

    Regeneron Reports Third Quarter 2014 Financial and Operating Results

  7. Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets

    Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets

  8. ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results

    ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results

  9. Research and Markets: Global Leather Chemicals Market Trends & Forecasts, 2019 - Tanning & Dyeing Chemicals, Beamhouse Chemicals and Finishing Chemicals Analysis of the $7 Billion Industry

    Research and Markets: Global Leather Chemicals Market Trends & Forecasts, 2019 - Tanning & Dyeing Chemicals, Beamhouse Chemicals and Finishing Chemicals Analysis of the $7 Billion Industry

  10. Germany Bets on 'Smart Factories' to Keep Its Manufacturing Edge

    Germany Bets on 'Smart Factories' to Keep Its Manufacturing Edge

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.